IMDX Earnings Insight Molecular Diagnostics Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–17 of 17
| Q1 2026 | 2026-03-31 | -0.12 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -1.65 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.91 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.57 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.26 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -4.66 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -2.36 | 2025-11-10 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.32 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.13 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -3.75 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -1.68 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.83 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.40 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -13.25 | 2024-04-16 | 10-K |
| Q3 2023 | 2022-09-30 | -5.22 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.63 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.11 | 2023-05-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.